1
2
#OpenInnovation
3
4
News & Events
Xeraya Capital Statement On Cloned Website
February 5, 2021
We do not solicit any transactions online through our website, nor are we involved in activities of any kind related to cryptocurrency. Read more
Allecra & Shanghai Haini Pharmaceutical Announce Exclusive Licensing Agreement
December 18, 2020
Shanghai Haini will manufacture, develop, and commercialize cefepime/enmetazobactam within Greater China. Read more
Acutus Medical Launches AcQBlate® Force Sensing Ablation System in Europe
December 7, 2020
The system incorporates first and only commercially available gold-tipped, irrigated, force-sensing radiofrequency ablation catheter on the market. Read more
5
#knowledgebase
6
7
News & Events
Xeraya Capital Statement On Cloned Website
February 5, 2021
We do not solicit any transactions online through our website, nor are we involved in activities of any kind related to cryptocurrency. Read more
InterVenn Receives Foundational Patent, CLIA Lab Certification
January 13, 2021
Accomplishment of multiple milestones in advancing the world's first glycoproteomics solutions. Read more
Allecra & Shanghai Haini Pharmaceutical Announce Exclusive Licensing Agreement
December 18, 2020
Shanghai Haini will manufacture, develop, and commercialize cefepime/enmetazobactam within Greater China. Read more
8
Portfolio Highlights
#PharmaBiotech
11
Our View
10
Our Focus
12
#PRI
22
Medical Technologies
#Portfolio
14
The fight continues,
we remain vigilant.
#NewNormal
#BreakTheChain
#FlattenTheCurve
16
Words from
the CEO
17
Portfolio Highlights
#PharmaBiotech
28
Pharmaceutical Biotech
#Portfolio
15
About Us
34
Biorenewables & Others
#Portfolio
19
WHAT'S TRENDING @ XERAYA
Intervenn Receives Foundational Patent
20
Our Team
21
23
Portfolio Highlights
#Biorenewables
30
Portfolio Highlights
#MedTech
25
26
ARE YOU
The Next
Big Thing?
Submit
A
Proposal
29
36
Career
#Xeraya
35
37
News & Events
Xeraya Capital Statement On Cloned Website
February 5, 2021
We do not solicit any transactions online through our website, nor are we involved in activities of any kind related to cryptocurrency. Read more
InterVenn Receives Foundational Patent, CLIA Lab Certification
January 13, 2021
Accomplishment of multiple milestones in advancing the world's first glycoproteomics solutions. Read more
Allecra & Shanghai Haini Pharmaceutical Announce Exclusive Licensing Agreement
December 18, 2020
Shanghai Haini will manufacture, develop, and commercialize cefepime/enmetazobactam within Greater China. Read more
32
#agro
33
Portfolio Highlights
#Biorenewables
38
Portfolio Highlights
#MedTech
39
40
Contact Us
41
